Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $9.00 at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH) had its price objective dropped by investment analysts at Truist Financial from $10.00 to $9.00 in a report issued on Friday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price suggests a potential upside of 36.05% from the stock’s current price.

A number of other equities analysts have also recently issued reports on AVAH. Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. UBS Group boosted their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a report on Thursday, January 15th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Barclays lifted their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research report on Friday, January 16th. Finally, William Blair started coverage on shares of Aveanna Healthcare in a research note on Monday, December 8th. They set an “outperform” rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $10.94.

Aveanna Healthcare Stock Up 4.3%

Shares of NASDAQ AVAH traded up $0.28 during midday trading on Friday, reaching $6.62. 733,519 shares of the company’s stock were exchanged, compared to its average volume of 1,193,720. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare has a 52-week low of $3.73 and a 52-week high of $10.32. The business’s fifty day moving average price is $7.88 and its two-hundred day moving average price is $8.50. The stock has a market capitalization of $1.38 billion, a PE ratio of 18.34 and a beta of 2.07.

Insiders Place Their Bets

In related news, insider Edwin C. Reisz sold 60,769 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $438,144.49. Following the completion of the sale, the insider directly owned 1,447,057 shares in the company, valued at approximately $10,433,280.97. This trade represents a 4.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jeff Shaner sold 173,225 shares of Aveanna Healthcare stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the sale, the chief executive officer directly owned 2,650,892 shares of the company’s stock, valued at approximately $19,112,931.32. The trade was a 6.13% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 998,595 shares of company stock worth $7,567,770. Corporate insiders own 7.80% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd increased its position in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares during the period. Invesco Ltd. grew its stake in shares of Aveanna Healthcare by 1,001.5% in the fourth quarter. Invesco Ltd. now owns 360,464 shares of the company’s stock worth $2,945,000 after acquiring an additional 327,738 shares during the last quarter. Mackenzie Financial Corp increased its position in Aveanna Healthcare by 12.7% during the fourth quarter. Mackenzie Financial Corp now owns 216,200 shares of the company’s stock worth $1,810,000 after acquiring an additional 24,447 shares during the period. Zimmer Partners LP acquired a new position in Aveanna Healthcare during the 4th quarter valued at $6,189,000. Finally, Voloridge Investment Management LLC acquired a new stake in Aveanna Healthcare in the 4th quarter worth $1,915,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results materially beat estimates — Aveanna reported revenue of $662.5M (up ~27% YoY) and an EPS beat (reported $0.83 vs. consensus near $0.13). The strong top‑line growth and big EPS beat are the main bullish catalysts. GlobeNewswire Q4 Results
• Positive Sentiment: Raymond James upgraded AVAH from Outperform to Strong‑Buy and set a $13 price target (~~97% above the recent price), which likely boosted investor demand and sentiment. Finviz (Raymond James Upgrade)
• Neutral Sentiment: Earnings call / transcripts available for detail — Investors can review management’s commentary on margins, organic growth and reimbursement trends in the Q4 call transcript to assess sustainability of recent results. Earnings Call Transcript
• Neutral Sentiment: Short‑interest data in recent reports appears unreliable/zeroed out (reported as 0 shares), so it doesn’t provide a clear signal on positioning or potential squeezes at the moment.
• Negative Sentiment: Fiscal‑2026 revenue/growth outlook disappointed some analysts and investors — coverage noted that the company’s revenue outlook trailed consensus, which pressured the stock despite the Q4 beat. That guidance miss is the main bearish offset to today’s gains. MSN (Guidance Miss)
• Negative Sentiment: Some outlets flagged the fiscal‑2026 guidance update as a reason for intracday weakness after the initial pop, highlighting that near‑term growth assumptions and reimbursement dynamics will be key watchpoints for investors. TipRanks (Guidance & Outlook)

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.